ORGANIC
LETTERS
2010
Vol. 12, No. 8
1700-1703
Total Synthesis of Kendomycin
Featuring Intramolecular Do¨tz
Benzannulation
Kyosuke Tanaka, Masahito Watanabe, Kodai Ishibashi, Hiroshi Matsuyama,
Yoko Saikawa,* and Masaya Nakata*
Department of Applied Chemistry, Faculty of Science and Technology, Keio
UniVersity, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Japan
saikawa@applc.keio.ac.jp; msynktxa@applc.keio.ac.jp
Received January 28, 2010
ABSTRACT
One-step formation of the ansa-skeleton realized the synthesis of kendomycin, an ansa-type quinone methide. The Fischer carbene complex
derived from the ansa-chain portion was subjected to the intramolecular Do¨tz benzannulation to afford the desired oxametacyclophane with
exclusive regioselectivity. Subsequent Claisen rearrangement, ortho oxidation of the resulting phenol derivative, and mild transformation from
p-quinone to p-quinone methide on a silica gel plate furnished kendomycin.
Natural ansamycins are quite attractive for organic chemists
and biologists from the point of both their fascinating
structures and impressive pharmacological profiles.1 The
complex ansamycin, kendomycin (1), has a unique quinone
methide architecture connected to a highly substituted
tetrahydropyran and possesses potent antibacterial and cy-
totoxic activities as well as activities as an endothelin receptor
antagonist and an antiosteoporotic agent.2 Since kendomycin
(1) was isolated from Streptomyces species,2 it has been
targeted by a number of synthetic organic chemists, and four
total syntheses3 and one formal total synthesis4 manipulating
each elaborated synthetic strategy have been reported. The
most common route for total syntheses of kendomycin and
other ansamycins generally involves elongation of an ali-
phatic ansa-chain from one or both sides of an aromatic core
followed by macrocyclization. In contrast, we conceived a
unique strategy to construct an ansa-framework featuring an
intramolecular Do¨tz benzannulation5,6 with simultaneous
macrocyclization. This challenging one-step formation of an
ansa-compound from a Fischer-type chromium-carbene
(3) (a) Yuan, Y.; Men, H.; Lee, C. J. Am. Chem. Soc. 2004, 126, 14720–
14721. (b) Smith, A. B., III.; Mesaros, E. F.; Meyer, E. A. J. Am. Chem.
Soc. 2005, 127, 6948–6949. (c) Smith, A. B., III.; Mesaros, E. F.; Meyer,
E. A. J. Am. Chem. Soc. 2006, 128, 5292–5299. (d) Lowe, J. T.; Panek,
J. S. Org. Lett. 2008, 10, 3813–3816. (e) Magauer, T.; Martin, H. J.; Mulzer,
J. Angew. Chem., Int. Ed. 2009, 48, 6032–6036. (f) Magauer, T.; Martin,
H. J.; Mulzer, J. Chem.sEur. J. 2010, 16, 507–519.
(1) For recent reviews on ansamycins, see: (a) Funayama, S.; Cordell,
G. A. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.;
Elsevier Science: Amsterdam, 2000; Vol. 23, pp 51-106. (b) Floss, H. G.;
Yu, T.-W. Chem. ReV. 2005, 105, 621–632. (c) Bryskier, A. In Antimicrobial
Agents; BryskierA., Ed; ASM Press: Washington, DC, 2005; pp 906-
924.
(2) (a) Funahashi, Y.; Kawamura, N.; Ishimaru, T. Jpn. Kokai Tokkyo
Koho 1996, 08231551; Chem. Abstr. 1996, 125, 326518. (b) Funahashi,
Y.; Ishimaru, T.; Kawamura, N. Jpn. Kokai Tokkyo Koho 1996, 08231552;
Chem. Abstr. 1997, 126, 6553. (c) Su, M. H.; Hosken, M. I.; Hotovec, B. J.;
Johnston, T. L. U. S. Patent 5728727, 1998;Chem. Abstr. 1998, 128, 239489.
(d) Bode, H. B.; Zeeck, A. J. Chem. Soc., Perkin Trans. 1 2000, 323–328.
(4) Bahnck, K. B.; Rychnovsky, S. D. J. Am. Chem. Soc. 2008, 130,
13177–13181.
(5) (a) Do¨tz, K. H. Angew. Chem., Int. Ed. Engl. 1975, 14, 644–645.
(b) Waters, M. L.; Wulff, W. D. In Organic Reactions; Overman, L. E.,
Ed.; Jon Wiley & Sons, Inc.: Hoboken, 2008; pp 121-623.
(6) For a partial synthesis of kendomycin using the intermolecular Do¨tz
reaction, see: White, J. D.; Smits, H. Org. Lett. 2005, 7, 235–238
.
10.1021/ol100229f 2010 American Chemical Society
Published on Web 03/12/2010